Abstract
Pantothenate kinase-associated neurodegeneration (PKAN) may serve as a model for Parkinson disease (PD) since many PKAN patients suffer from parkinsonism and both conditions lead to iron accumulation in the basal ganglia. We screened the gene coding for pantothenate kinase 2 (PANK2) for sequence variants in PD. We found no mutations in 67 PD patients with affected sibs or early-onset disease. Moreover, PANK2 polymorphisms were not associated with late-onset idiopathic PD in 339 patients. We conclude that PANK2 variants exert, if any, only a very small effect in the genetic risk of PD. © 2005 Elsevier Ireland Ltd. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Klopstock, T., Elstner, M., Lücking, C. B., Müller-Myhsok, B., Gasser, T., Botz, E., … Hörtnagel, K. (2005). Mutations in the pantothenate kinase gene PANK2 are not associated with Parkinson disease. Neuroscience Letters, 379(3), 195–198. https://doi.org/10.1016/j.neulet.2004.12.061
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.